Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Korro Bio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 86
- +2 vs. Q4 2021
- Shares held
- 15.9M
- −1.85M (−10.5%) vs. Q4 2021
- Total value
- $33.1M
- −$57.1M (−63.3%) vs. Q4 2021
- New holders
- 22
- 19 more added
- Sold out
- 20
- 29 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 106 | $190.1M |
| Q1 2026 | 99 | $144.8M |
| Q4 2025 | 83 | $60.6M |
| Q3 2025 | 92 | $465.5M |
| Q2 2025 | 71 | $114.8M |
| Q1 2025 | 75 | $169.0M |
| Q4 2024 | 84 | $359.6M |
| Q3 2024 | 71 | $285.3M |
| Q2 2024 | 64 | $285.7M |
| Q1 2024 | 49 | $618.6M |
| Q4 2023 | 40 | $301.5M |
| Q3 2023 | 42 | $2.58M |
| Q2 2023 | 41 | $1.67M |
| Q1 2023 | 43 | $2.52M |
| Q4 2022 | 50 | $28.3M |
| Q3 2022 | 55 | $14.1M |
| Q2 2022 | 58 | $13.0M |
| Q1 2022 | 86 | $33.1M |
| Q4 2021 | 84 | $90.2M |
| Q3 2021 | 88 | $130.4M |
| Q2 2021 | 91 | $193.9M |
| Q1 2021 | 115 | $186.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Korro Bio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,830−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,568−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −987−100.0% | Sold out |
| Retirement Planning Co of New England, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −182−100.0% | Sold out |